Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Gastrostomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Breakthrough Pain 1

Interventions

Cyclophosphamide 1732 Radiotherapy 1592 Cisplatin 1524 Carboplatin 1295 Gemcitabine 1203 Paclitaxel 1100 Bevacizumab 1059 Docetaxel 1043 pembrolizumab 1020 Capecitabine 979 Oxaliplatin 976 Fluorouracil 914 Dexamethasone 827 Rituximab 778 Nivolumab 773 Magnetic Resonance Spectroscopy 728 Etoposide 703 Doxorubicin 696 Irinotecan 661 Radiosurgery 660 Drug Therapy 659 Cytarabine 634 fludarabine 616 Leucovorin 577 Lenalidomide 525 fludarabine phosphate 478 Radiation 466 Temozolomide 463 Filgrastim 462 Cetuximab 457

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡